Just published a new study in @MSARDJournal with co-authors @LauraPiccio, @AnneHCross1, and @LauraGhezzi10. Together, we uncovered dysregulated functions of MDSCs in MS and demonstrated how glucocorticoids can reverse it by downregulating miR-223. https://t.co/lExNHl17ET
COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab is now published online and available in
Neurology and Therapy DOI 10.1007/s40120-022-00341-z
@SpringerNature@AnneHCross1
The feeling of seeing your first paper as the last author!! Thanks to all that made it possible! Check it out here: https:///articles/10.1186/s40478-022-01328-5
New paper available! Take a look. We used quantitative GRE MRI imaging to measure R2t* (a component of R2*) and develop a biomarker of progressive MS. @AnneHCross1@WashU_MSCenter@WashUNeurology
https://t.co/sHx9hQcyFG
Great talk by Claudia Cantoni @Clodida showing her data on Single Cell RNA Sequencing in MS CSF and identified specific MS cell-subset signatures, including the presence of plasma cells and a reduction of naïve and memory non-switched B cells
@ACTRIMS#MultipleSclerosis
Our last publication is out! Longitudinal multi-omics profiling of host immune status, metabolome, gut microbiome, and dietary habits in MS patients https://t.co/4pmLkIQO8X @LauraGhezzi10@LauraPiccio@AnneHCross1
Do you want to learn how the gut brain axis could contribute to the MS pathogenesis? Read our last review article on @jclinicalinvest! Congrats to the first author @LauraGhezzi10 and to our mentor @LauraPiccio! Great team work! https://t.co/rdqG10qp0R
It’s a great emotion to inaugurate the official Twitter account of 🇮🇹 Society of Neurology for Dementia
Our goal is to ease exchanges, spread knowledge, interact, create sharing, inform about projects that SINdem will build to approach #Dementia
Let's walk together
Stay with us